Literature DB >> 2101519

Thrombocytopenia and leptospirosis.

A C Nicodemo1, G Del Negro, V Amato Neto.   

Abstract

The present study has intended to contribute to the elucidation of the pathogenic mechanisms, involved in the thrombocytopenia and in the bleeding diathesis seen in the course of Leptospirosis. The group of cases included in the present prospective study consisted of 30 patients with Leptospirosis, admitted to the Infectious and Parasitic Diseases Ward, Hospital das Clínicas, Faculty of Medicine, University of São Paulo. The following possible mechanisms of thrombocytopenia have been considered and therefore investigated: platelet consumption, due to disseminated intravascular coagulation; immune-mediated platelet destruction, due to platelet-associated antibodies and an inhibited platelet production in the bone marrow. Thrombocytopenia occurred in 86.6% of 30 patients and did not seem to be immune-mediated by platelet-associated antibodies. Furthermore it did not seem to be due to a disseminated intravascular coagulation consumption. Although there was a statistically-significant correlation between bone marrow platelet production and platelet counts we think that the static microscopic examination of a bone marrow aspirate cannot accurately depict the dynamic mechanisms of platelet production when these cells are being consumed in peripheral blood. Vasculitis should be considered as the most important factor for the pathogenesis of the bleeding disturbances in Leptospirosis. However, we believe that thrombocytopenia, uremia and coagulation disorders, individually or as a group, should be included among the contributing factors that lead to and worsen bleeding episodes, which represent the leading cause of death in this disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2101519     DOI: 10.1590/s0036-46651990000400004

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  8 in total

1.  Comparative study on infection-induced thrombocytopenia among returned travellers.

Authors:  K-H Herbinger; M Schunk; H D Nothdurft; F von Sonnenburg; T Löscher; G Bretzel
Journal:  Infection       Date:  2012-02-17       Impact factor: 3.553

2.  Therapeutic dilemma in a case of acute coronary syndrome (ACS).

Authors:  Smitha Bhat; Amith D'Souza; Divya Fernandes; Gautam Rajan
Journal:  BMJ Case Rep       Date:  2013-01-28

3.  Alveolar septal deposition of immunoglobulin and complement parallels pulmonary hemorrhage in a guinea pig model of severe pulmonary leptospirosis.

Authors:  Jarlath E Nally; Chavit Chantranuwat; Xiao-Yang Wu; Michael C Fishbein; Martha M Pereira; João José Pereira Da Silva; David R Blanco; Michael A Lovett
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

4.  Thrombocytopenia in leptospirosis and role of platelet transfusion.

Authors:  Jayashree Sharma; Moushumi Suryavanshi
Journal:  Asian J Transfus Sci       Date:  2007-07

5.  Thrombocytopenia in the experimental leptospirosis of guinea pig is not related to disseminated intravascular coagulation.

Authors:  Hong-Liang Yang; Xu-Cheng Jiang; Xiang-Yan Zhang; Wen-Jun Li; Bao-Yu Hu; Guo-Ping Zhao; Xiao-Kui Guo
Journal:  BMC Infect Dis       Date:  2006-02-02       Impact factor: 3.090

Review 6.  Leptospiral pathogenomics.

Authors:  Jason S Lehmann; Michael A Matthias; Joseph M Vinetz; Derrick E Fouts
Journal:  Pathogens       Date:  2014-04-10

7.  Hemorrhagic, Hemostatic, and Thromboelastometric Disorders in 35 Dogs with a Clinical Diagnosis of Leptospirosis: A Prospective Study.

Authors:  A Barthélemy; M Magnin; C Pouzot-Nevoret; J-M Bonnet-Garin; M Hugonnard; I Goy-Thollot
Journal:  J Vet Intern Med       Date:  2016-12-02       Impact factor: 3.333

Review 8.  Phagocyte Escape of Leptospira: The Role of TLRs and NLRs.

Authors:  Ignacio Santecchia; María Florencia Ferrer; Monica Larucci Vieira; Ricardo Martín Gómez; Catherine Werts
Journal:  Front Immunol       Date:  2020-10-06       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.